|Articles|December 1, 2002
- Pharmaceutical Executive-12-01-2002
Table of Contents (December 2002)
Table of Contents
Advertisement
Articles in this issue
over 23 years ago
The Pain Pipelineover 23 years ago
FDA in Motionover 23 years ago
Every Employee, Every Dayover 23 years ago
The Geometry of RiskAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
The Risks and Benefits of FDA Reviewing Real-Time Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5